FDA Inspection 1206442 — BroadMaster Biotech Corp.
The FDA completed an inspection of BroadMaster Biotech Corp. on Apr 13, 2023 in Taoyuan City. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 13, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Taoyuan City (Taiwan)